Ten stocks soared by double digits on Tuesday, outperforming Wall Street, as investors took heart from a flurry of corporate and industry developments, including acquisition deals...
Keep Reading →
March 31 - Market Movers, News
Apellis Pharmaceuticals, Inc.
Keep Reading →
March 31 - News
On March 26, Stephanie Link, Hightower chief investment strategist, appeared on CNBC's ‘Squawk Box’ to talk about the latest market trends, where investors can find opportunities...
Keep Reading →
March 29 - Hedge Funds, News
On March 5, Anupam Rama from JPMorgan increased the price target on Apellis Pharmaceuticals Inc. (NASDAQ:APLS) from $36 to $37.
Keep Reading →
March 10 - News
On February 5, J.P. Morgan shared its views on trends that are expected to define healthcare in 2026.
Keep Reading →
March 9 - Hedge Funds, News
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the best high short interest stocks with biggest upside potential.
Keep Reading →
January 30 - News
On January 27, Sherry Paul, a senior portfolio manager at Morgan Stanley, appeared on CNBC's 'Closing Bell' to discuss whether more volatility is ahead, following a volatile week...
Keep Reading →
January 28 - Hedge Funds, News
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the best upside stocks to buy now.
Keep Reading →
November 30 - News
On November 14, Alli McCartney, UBS Private Wealth Management managing director, joined 'Squawk Box' on CNBC to discuss the latest market trends and what to make of the recent...
Keep Reading →
November 29 - Hedge Funds, News
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) ranks among the most oversold biotech stocks to invest in.
Keep Reading →
November 25 - News
Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value and healthcare.
Keep Reading →
November 23 - Hedge Funds, News
On September 27, Wharton professor emeritus and WisdomTree senior economist Jeremy Siegel joined CNBC for an interview to discuss the latest PCE report and what the data reveal...
Keep Reading →
September 29 - Hedge Funds, News
Apellis Pharmaceuticals, Inc.
Keep Reading →
August 13 - News
The latter half of the 2025 market is caught between conflicting signals.
Keep Reading →
August 9 - Hedge Funds, Market Movers, News
In a market note on Wednesday, Scotiabank increased its price target for Apellis Pharmaceuticals, Inc.’s (NASDAQ:APLS) stock to $22 from $20 previously, and maintained a “...
Keep Reading →
August 1 - News
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the biotech stocks to buy according to Wall Street analysts.
Keep Reading →
July 31 - News
On July 8, Jared Holz, Mizuho, joined 'Closing Bell Overtime' on CNBC to discuss if the biotech sector is ready for a breakout.
Keep Reading →
July 31 - Hedge Funds, News
Apellis Pharmaceuticals Inc. (NASDAQ:APLS) is one of the most promising stocks according to Wall Street analysts.
Keep Reading →
July 9 - News
On July 3, Scott Wren, Wells Fargo senior global market strategist, and Adam Crisafulli, Vital Knowledge founder, joined 'Closing Bell Overtime' on CNBC to talk about the current...
Keep Reading →
July 8 - Hedge Funds, News
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is one of the 13 Best Pharma Stocks to Buy According to Wall Street Analysts.
Keep Reading →
July 6 - News
On June 24, Jared Holz, Mizuho's healthcare strategist, appeared on CNBC's 'Fast Money' to talk about competition in the obesity drug space.
Keep Reading →
July 5 - Hedge Funds, News
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is among the best growth stocks to invest in for the next 5 years. The General Counsel of Apellis Pharmaceuticals, Inc.
Keep Reading →
July 2 - News
Before making any decision, whether big or small, we instinctively weigh its long-term impact, and this is particularly true in the case of stocks.
Keep Reading →
June 26 - Hedge Funds, News
We recently published a list of These 10 Stocks Blew Past Expectations.
Keep Reading →
June 3 - News
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.
Keep Reading →
May 8 - Hedge Funds, Industries, News
On April 28, Darrell Cronk, Wells Fargo Wealth and Investment Management CIO, appeared on CNBC's 'Squawk on the Street' to discuss market outlooks and what investors should look...
Keep Reading →
April 29 - Hedge Funds, News
Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet.
Keep Reading →
April 21 - Hedge Funds, News
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
Keep Reading →
March 30 - Hedge Funds, News
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Keep Reading →
March 24 - Hedge Funds, News
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and...
Keep Reading →
February 22 - Hedge Funds, Industries, News
Healthcare costs and spending have been rising in the US.
Keep Reading →
February 19 - Hedge Funds, Industries, News
Ever heard of the “January effect?” In case you haven’t, a “January effect” is considered a phenomenon in the stock market where stock prices, most commonly of small...
Keep Reading →
February 18 - Insider Trading, News
Why should investors analyze insider trading activity? Insiders, or people in high positions within a company—such as executives and directors—can have crucial insights into...
Keep Reading →
February 11 - Insider Trading, News
The ability to successfully make money through investment requires deep thinking and analysis.
Keep Reading →
September 11 - Hedge Funds, News
According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023.
Keep Reading →
September 2 - Hedge Funds, Industries, News
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
Keep Reading →
December 18 - Market Movers, News
Below we present the list of 5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Keep Reading →
November 4 - Hedge Funds, News
In this article, we discuss the 5 stocks receiving price-target hike from Wall Street analysts.
Keep Reading →
August 24 - Market Movers, News
In this article, we discuss 5 worst performing healthcare stocks in 2023.
Keep Reading →
August 13 - Hedge Funds, News
In this article, we will take a look at the 5 oversold healthcare stocks to buy.
Keep Reading →
August 12 - Hedge Funds, Lists
In this article, we discuss 5 worst performing biotech stocks in 2023.
Keep Reading →
August 8 - News
In this piece, we will take a look at five oversold midcap stocks to buy.
Keep Reading →
August 4 - News
In this article, we discuss the 5 stocks receiving downgrades from analysts.
Keep Reading →
August 3 - News
In this article, we will take a look at the 5 oversold NASDAQ stocks to buy.
Keep Reading →
August 1 - Hedge Funds, Lists
In this article, we discuss 15 worst performing NASDAQ stocks in 2023.
Keep Reading →
July 31 - Hedge Funds, News
In this article, we will take a look at the 5 oversold biotech stocks to buy.
Keep Reading →
July 29 - News
In this article, we will take a look at the 12 stocks with biggest upside potential according to analysts.
Keep Reading →
July 28 - Hedge Funds, Lists
Australian stocks also suffered the same fate in 20222, coming under immense pressure as the Reserve Bank of Australia embarked on an aggressive monetary policy tightening.
Keep Reading →
July 28 - News
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
Keep Reading →
April 26 - Hedge Funds, News
Hedge Fund Resource Center 
